Technology-enabled scientific communications company, Envision Pharma Group (“Envision”), announces a partnership with Scite, following their acquisition by Research Solutions, Inc. in 2023 (https://www.researchsolutions.com/resources/press-releases/research-solutions-announces-acquisition-of-scite). Smart Citations are now fully integrated into the publication details held within the Library, Datavision, and Scientific Communication Platform (SCP) modules in iEnvision® – the global medical affairs platform.
Scite offers a revolutionary citation index, Smart Citations, that enriches research by providing context and classification for each citation, such as whether it supports, mentions, or contrasts the cited paper, additionally, they also have the most comprehensive retraction data available, thereby enhancing the reliability of literature reviews. By tapping into an expansive database of over one billion Smart Citations and utilizing generative Artificial Intelligence (AI), Scite aids researchers by swiftly synthesizing citation data into transparent and trustworthy formats. Designed for a broad audience including students, academics, and medical writers, Scite’s unique capabilities and trustworthy AI, underpinned by exclusive publisher agreements for data mining, set a new standard in scholarly research and citation analysis.
This Smart Citation functionality, immediately available to iEnvision customers with a Scite subscription, sits alongside and enhances the existing article-level metrics provided in iEnvision through integrations with Altmetric and Scopus.
Jim Streeter, Chief Technology Officer, President of Technology, said, “As authors and medical writers use iEnvision to develop and manage their publications, rapid access to Scite results in greater efficiency, thereby accelerating the research process. Now that Scite is part of Research Solutions, Inc., we are further motivated to explore broader collaborations to bring even greater value and efficiency to our customers.”
Dr. Josh Nicholson, co-founder of Scite and now Chief Strategy Officer of Research Solutions, added, “We’re very happy to be working with Envision to provide a powerful integration between the two platforms. Smart Citations are already used by various pharmaceutical companies and communications agencies and we’re happy to surface them in iEnvision for a more streamlined workflow.”
About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies, including all of the top 20 pharmaceutical companies. Envision supports clients across the product life cycle through a comprehensive suite of services and industry-leading technology solutions that include AI and natural language processing, commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. Learn more at: www.envisionpharmagroup.com.
About Research Solutions, Inc.
Research Solutions, Inc. (NASDAQ: RSSS) provides cloud-based technologies to streamline the process of accessing, managing, and creating intellectual property. Since its founding, the company has been a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on our family of products, powered by AI and NLP technologies, to support the innovation process from end to end with the most comprehensive information and knowledge tools on the market. For more information and details, please visit: www.researchsolutions.com.
About Scite
Established in 2018, scite is a Brooklyn-based startup that revolutionizes how researchers discover and evaluate research through Smart Citations. Smart Citations transcend conventional references by offering in-text sentences, citing relevant sections, and providing a classification that denotes either support or contrast to the cited claim. scite’s powerful, innovative solutions equip researchers worldwide in various career stages. The company has received multiple accolades for its groundbreaking work in next-generation citations, including the ISMTE People’s Choice Award and ALPSP Award for Innovation in Publishing.
About Research Solutions, Inc.
Research Solutions, Inc. (NASDAQ: RSSS) provides cloud-based technologies to streamline the process of accessing, managing, and creating intellectual property. Since its founding, the company has been a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on our family of products, powered by AI and NLP technologies, to support the innovation process from end to end with the most comprehensive information and knowledge tools on the market. For more information and details, please visit: www.researchsolutions.com.
About iEnvision Library
Library, built on the iEnvision medical project management platform, serves as a central repository for the enterprise-wide storage and sharing of final, approved scientific and medical materials such as publications and slide decks. Embedding Smart Citations in Library allows an at-a-glance view of the total number of times a paper has been cited and the context of these citations. Learn more at: www.envisionpharmagroup.com/technology/i-envision.
About iEnvision Datavision®
The iEnvision Datavision module is designed to drive the compliant and efficient management of scientific and medical publications. With role-specific dashboards, publication managers can access the detailed information needed to start and manage publications. Containing built-in checklists and system validation, it ensures publications comply with Good Publication Practice and the International Committee of Medical Journal Editors (ICMJE) requirements. Learn more at: www.envisionpharmagroup.com/technology/i-envision.
About iEnvision Scientific Communication Platform
iEnvision SCP is a centralized medical affairs solution, linking key scientific themes and statements to product-related assets such as publications, slides, and videos. The common template of SCP themes, key statements, and supporting statements maintains simple user navigation and a standardized approach to the formatting and development of SCPs – with a lexicon designed to ensure a consistent use of language that includes preferred and prohibited terms. Learn more at: www.envisionpharmagroup.com/technology/i-envision.